Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM203602
Substrate
n/a
Meas. Tech.
IMAP technology (Molecular Devices)
pH
7.2±n/a
Temperature
298.15±n/a K
IC50
22±n/a nM
Comments
extracted
Citation
 Seganish, WMBrumfield, SNLim, JMatasi, JJMcElroy, WTTulshian, DBLavey, BJAltman, MDGibeau, CRLampe, JWMethot, JZhu, L Aminopyrimidinones as interleukin receptor-associated kinase inhibitors US Patent  US9221809 Publication Date 12/29/2015 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM203602
Synonyms:
US9221809, 160
Type:
Small organic molecule
Emp. Form.:
C26H31N9OS
Mol. Mass.:
517.649
SMILES:
Cc1cnc(C)c(n1)N1CCN(CC1)c1nc(N[C@@H]2CCCNC2)c(-c2nc3ccccc3s2)c(=O)[nH]1 |r|
Structure:
Search PDB for entries with ligand similarity: